Free Trial

24,851 Shares in Azenta, Inc. (NASDAQ:AZTA) Acquired by Wakefield Asset Management LLLP

Azenta logo with Medical background

Wakefield Asset Management LLLP purchased a new position in Azenta, Inc. (NASDAQ:AZTA - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 24,851 shares of the company's stock, valued at approximately $861,000. Wakefield Asset Management LLLP owned about 0.05% of Azenta as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of AZTA. Farther Finance Advisors LLC boosted its stake in shares of Azenta by 788.1% during the first quarter. Farther Finance Advisors LLC now owns 968 shares of the company's stock valued at $33,000 after purchasing an additional 859 shares during the period. Headlands Technologies LLC purchased a new stake in Azenta in the fourth quarter worth about $40,000. Covestor Ltd lifted its stake in Azenta by 64.2% in the fourth quarter. Covestor Ltd now owns 2,043 shares of the company's stock worth $102,000 after acquiring an additional 799 shares during the period. Quarry LP bought a new position in Azenta in the fourth quarter worth about $110,000. Finally, Sterling Capital Management LLC raised its holdings in Azenta by 39.8% in the fourth quarter. Sterling Capital Management LLC now owns 2,856 shares of the company's stock worth $143,000 after purchasing an additional 813 shares in the last quarter. Institutional investors own 99.08% of the company's stock.

Azenta Stock Down 1.5%

Shares of AZTA traded down $0.52 during mid-day trading on Thursday, hitting $33.96. 509,135 shares of the company traded hands, compared to its average volume of 972,295. Azenta, Inc. has a 1-year low of $23.91 and a 1-year high of $63.58. The company has a market capitalization of $1.55 billion, a PE ratio of -24.43 and a beta of 1.64. The business has a 50 day moving average of $30.06 and a 200 day moving average of $36.18.

Azenta (NASDAQ:AZTA - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a negative net margin of 10.31% and a positive return on equity of 1.30%. During the same quarter last year, the company posted $0.06 EPS. Azenta's quarterly revenue was up 5.1% compared to the same quarter last year. As a group, research analysts expect that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Needham & Company LLC reduced their target price on shares of Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a report on Wednesday, May 7th. Stephens upgraded shares of Azenta to a "hold" rating and set a $35.00 target price for the company in a report on Tuesday. Finally, Evercore ISI boosted their target price on shares of Azenta from $29.00 to $35.00 and gave the stock an "in-line" rating in a report on Tuesday, July 8th.

Check Out Our Latest Stock Analysis on AZTA

About Azenta

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

See Also

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Should You Invest $1,000 in Azenta Right Now?

Before you consider Azenta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.

While Azenta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines